Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers

JR Atack, AM Prior, SR Fletcher, K Quirk, R McKernan and CI Ragan

Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, England.

In order to enhance the entry into cells of L-690,330, a bisphosphonate inhibitor of inositol monophosphatase (IMPase; a key, enzyme in the phosphatidylinositol (Pl) cell signaling pathway), the tetrapivaloyloxymethyl ester prodrug, L-690,488 [tetrapivaloyloxymethyl 1-(4-hydroxyphenoxy)ethane-1,1-bisphosphonate], was synthesized. The effects of L-690,488 were studied in cholinergically (carbachol)- stimulated rat cortical slices and Chinese hamster ovary cells stably transfected with the human muscarinic m1 receptor (m1 CHO cells). The accumulation of [3H]inositol monophosphates or [3H]cytidine monophosphorylphosphatidate ([3H]CMP-PA) after [3H]inositol or [3H]cytidine prelabeling, respectively, and inositol 1,4,5- trisphosphate and inositol 1,3,4,5-tetrakisphosphate mass were measured. In rat cortical slices and m1 CHO cells, the maximum response and time course of accumulation of [3H]inositol monophosphates for L- 690,488 and lithium were similar. However, the concentrations of L- 690,488 required to produce these effects (EC50 values of 3.7 +/- 0.9 and 1.0 +/- 0.2 microM in cortical slices and m1 CHO cells, respectively) were much lower than with lithium (0.3-1.5 mM). Likewise, the time course and maximum accumulation of [3H] CMP-PA in L-690,488- treated m1 CHO cells was similar to lithium but L-690,488 was again much more potent (EC50 values = 3.5 +/- 0.3 microM and 0.52 +/- 0.03 mM for L-690,488 and lithium, respectively). In addition, L-690,488 attenuated the carbachol-induced elevation of inositol 1,4,5- trisphosphate and inositol 1,3,4,5-tetrakisphosphate in m1 CHO cells, an effect reported previously with lithium. These results are all consistent with L-690,488 and lithium both depleting intracellular inositol as a consequence of inhibition of IMPase. That these effects of L-690,488 on the PI cycle are indeed due to inositol depletion is shown by the observation that the effects of L-690,488 on CMP-PA accumulation could be overcome by addition of exogenous myo-inositol (EC50 = 1.7 +/- 0.5 mM). These data show that inhibition of IMPase produces effects on the PI cycle comparable to lithium. As a corollary, the effects of lithium on the PI cycle are therefore consistent with its major mechanism of action being inhibition of IMPase.

Volume 270, Issue 1, pp. 70-76, 07/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J. A. Quiroz, T. D. Gould, and H. K. Manji MOLECULAR EFFECTS of lithium Mol. Interv., October 1, 2004; 4(5): 259 - 272. [Abstract] [Full Text] [PDF]

				W. Zheng, P. E. Brandish, D. G. Kolodin, E. M. Scolnick, and B. Strulovici High-Throughput Cell-Based Screening Using Scintillation Proximity Assay for the Discovery of Inositol Phosphatase Inhibitors J Biomol Screen, March 1, 2004; 9(2): 132 - 140. [Abstract] [PDF]

				X. Chen, E. G. McMahon, and E. A. Gulve Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP1 Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E272 - E277. [Abstract] [Full Text] [PDF]

				M. Hong, D. C. R. Chen, P. S. Klein, and V. M.-Y. Lee Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3 J. Biol. Chem., October 3, 1997; 272(40): 25326 - 25332. [Abstract] [Full Text] [PDF]